Literature DB >> 16353992

Cyclodextrins in drug delivery: an updated review.

Rajeswari Challa1, Alka Ahuja, Javed Ali, R K Khar.   

Abstract

The purpose of this review is to discuss and summarize some of the interesting findings and applications of cyclodextrins (CDs) and their derivatives in different areas of drug delivery, particularly in protein and peptide drug delivery and gene delivery. The article highlights important CD applications in the design of various novel delivery systems like liposomes, microspheres, microcapsules, and nanoparticles. In addition to their well-known effects on drug solubility and dissolution, bioavailability, safety, and stability, their use as excipients in drug formulation are also discussed in this article. The article also focuses on various factors influencing inclusion complex formation because an understanding of the same is necessary for proper handling of these versatile materials. Some important considerations in selecting CDs in drug formulation such as their commercial availability, regulatory status, and patent status are also summarized. CDs, because of their continuing ability to find several novel applications in drug delivery, are expected to solve many problems associated with the delivery of different novel drugs through different delivery routes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16353992      PMCID: PMC2750546          DOI: 10.1208/pt060243

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  189 in total

1.  Effect of aging on the dissolution stability of glibenclamide/beta-cyclodextrin complex.

Authors:  R J Babu; J K Pandit
Journal:  Drug Dev Ind Pharm       Date:  1999-11       Impact factor: 3.225

2.  The equilibrium constant of beta-cyclodextrin-phenolphtalein complex; influence of temperature and tetrahydrofuran addition.

Authors:  P K Zarzycki; H Lamparczyk
Journal:  J Pharm Biomed Anal       Date:  1998-10       Impact factor: 3.935

3.  Use of beta-cyclodextrins to prevent modifications of the properties of carbopol hydrogels due to carbopol-drug interactions.

Authors:  Haydee Blanco-Fuente; Blanca Esteban-Fernández; José Blanco-Méndez; Francisco-Javier Otero-Espinar
Journal:  Chem Pharm Bull (Tokyo)       Date:  2002-01       Impact factor: 1.645

4.  Effects of structure of beta-cyclodextrin-containing polymers on gene delivery.

Authors:  S J Hwang; N C Bellocq; M E Davis
Journal:  Bioconjug Chem       Date:  2001 Mar-Apr       Impact factor: 4.774

Review 5.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.

Authors:  T Loftsson; M E Brewster
Journal:  J Pharm Sci       Date:  1996-10       Impact factor: 3.534

6.  Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.

Authors:  E Suihko; O Korhonen; T Järvinen; J Ketolainen; P Jarho; E Laine; P Paronen
Journal:  Int J Pharm       Date:  2001-03-14       Impact factor: 5.875

Review 7.  Itraconazole in cyclodextrin solution.

Authors:  D A Stevens
Journal:  Pharmacotherapy       Date:  1999-05       Impact factor: 4.705

8.  Formulation of triamcinolone acetonide pellets suitable for coating and colon targeting.

Authors:  M E Villar-López; L Nieto-Reyes; S Anguiano-Igea; F J Otero-Espinar; J Blanco-Méndez
Journal:  Int J Pharm       Date:  1999-03-15       Impact factor: 5.875

9.  Development of formulations that enhance physical stability of viral vectors for gene therapy.

Authors:  M A Croyle; X Cheng; J M Wilson
Journal:  Gene Ther       Date:  2001-09       Impact factor: 5.250

10.  Influence of betacyclodextrin on the release of poorly soluble drugs from inert and hydrophilic heterogeneous polymeric matrices.

Authors:  M E Sangalli; L Zema; A Maroni; A Foppoli; F Giordano; A Gazzaniga
Journal:  Biomaterials       Date:  2001-10       Impact factor: 12.479

View more
  150 in total

1.  Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.

Authors:  Ketan Hippalgaonkar; Waseem Gul; Mahmoud A ElSohly; Michael A Repka; Soumyajit Majumdar
Journal:  AAPS PharmSciTech       Date:  2011-06-03       Impact factor: 3.246

Review 2.  The nature of amyloid-like glucagon fibrils.

Authors:  Jesper Søndergaard Pedersen
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

Review 3.  Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.

Authors:  Justin S LaFountaine; James W McGinity; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2015-08-26       Impact factor: 3.246

4.  Cavamax W7 composite ethosomal gel of clotrimazole for improved topical delivery: development and comparison with ethosomal gel.

Authors:  Nida Akhtar; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2012-01-27       Impact factor: 3.246

5.  Ultrashort peptide bioconjugates are exclusively antifungal agents and synergize with cyclodextrin and amphotericin B.

Authors:  Christopher J Arnusch; Hannah Ulm; Michaele Josten; Yana Shadkchan; Nir Osherov; Hans-Georg Sahl; Yechiel Shai
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

6.  Preparation and characterization of inclusion complexes of a hemisuccinate ester prodrug of delta9-tetrahydrocannabinol with modified beta-cyclodextrins.

Authors:  Sampada B Upadhye; Swapnil J Kulkarni; Soumyajit Majumdar; Mitchell A Avery; Waseem Gul; Mahmoud A ElSohly; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2010-03-24       Impact factor: 3.246

7.  Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique.

Authors:  Tijana Mihajlovic; Kyriakos Kachrimanis; Adrijana Graovac; Zorica Djuric; Svetlana Ibric
Journal:  AAPS PharmSciTech       Date:  2012-04-26       Impact factor: 3.246

8.  Effect of auxiliary substances on complexation efficiency and intrinsic dissolution rate of gemfibrozil-beta-CD complexes.

Authors:  Fareen Sami; Betty Philip; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2009-12-15       Impact factor: 3.246

9.  Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.

Authors:  Sateeshkumar Sathigari; Gurkishan Chadha; Y-H Phillip Lee; Nydeia Wright; Daniel L Parsons; Vijay K Rangari; Oladiran Fasina; R Jayachandra Babu
Journal:  AAPS PharmSciTech       Date:  2009-01-16       Impact factor: 3.246

Review 10.  Approaches for enhancing oral bioavailability of peptides and proteins.

Authors:  Jwala Renukuntla; Aswani Dutt Vadlapudi; Ashaben Patel; Sai H S Boddu; Ashim K Mitra
Journal:  Int J Pharm       Date:  2013-02-18       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.